Annual long term liabilities:
$41.09M-$17.06M(-29.34%)Summary
- As of today (June 1, 2025), AGIO annual total long term liabilities is $41.09 million, with the most recent change of -$17.06 million (-29.34%) on December 31, 2024.
- During the last 3 years, AGIO annual long term liabilities has fallen by -$44.85 million (-52.19%).
- AGIO annual long term liabilities is now -88.56% below its all-time high of $359.06 million, reached on December 31, 2020.
Performance
AGIO Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$36.62M-$4.46M(-10.86%)Summary
- As of today (June 1, 2025), AGIO quarterly total long term liabilities is $36.62 million, with the most recent change of -$4.46 million (-10.86%) on March 31, 2025.
- Over the past year, AGIO quarterly long term liabilities has dropped by -$17.47 million (-32.30%).
- AGIO quarterly long term liabilities is now -89.80% below its all-time high of $359.06 million, reached on December 31, 2020.
Performance
AGIO quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AGIO Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.3% | -32.3% |
| 3 y3 years | -52.2% | -55.7% |
| 5 y5 years | -73.9% | -65.0% |
AGIO Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.2% | at low | -55.7% | at low |
| 5 y | 5-year | -88.6% | at low | -89.8% | at low |
| alltime | all time | -88.6% | +537.1% | -89.8% | +467.9% |
AGIO Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $36.62M(-10.9%) |
| Dec 2024 | $41.09M(-29.3%) | $41.09M(-10.0%) |
| Sep 2024 | - | $45.67M(-8.5%) |
| Jun 2024 | - | $49.92M(-7.7%) |
| Mar 2024 | - | $54.10M(-7.0%) |
| Dec 2023 | $58.14M(-22.8%) | $58.14M(-6.2%) |
| Sep 2023 | - | $61.99M(-5.8%) |
| Jun 2023 | - | $65.78M(-5.6%) |
| Mar 2023 | - | $69.66M(-7.5%) |
| Dec 2022 | $75.28M(-12.4%) | $75.28M(-1.7%) |
| Sep 2022 | - | $76.55M(-4.3%) |
| Jun 2022 | - | $80.00M(-3.2%) |
| Mar 2022 | - | $82.61M(-3.9%) |
| Dec 2021 | $85.94M(-76.1%) | $85.94M(-3.3%) |
| Sep 2021 | - | $88.84M(-3.6%) |
| Jun 2021 | - | $92.14M(-3.3%) |
| Mar 2021 | - | $95.30M(-73.5%) |
| Dec 2020 | $359.06M(+128.2%) | $359.06M(+0.2%) |
| Sep 2020 | - | $358.23M(+1.4%) |
| Jun 2020 | - | $353.32M(+237.8%) |
| Mar 2020 | - | $104.58M(-33.5%) |
| Dec 2019 | $157.33M(+103.2%) | $157.33M(-0.4%) |
| Sep 2019 | - | $157.89M(-2.3%) |
| Jun 2019 | - | $161.69M(+33.7%) |
| Mar 2019 | - | $120.97M(+56.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $77.42M(-46.2%) | $77.42M(-8.0%) |
| Sep 2018 | - | $84.12M(-6.8%) |
| Jun 2018 | - | $90.22M(-9.6%) |
| Mar 2018 | - | $99.83M(-30.6%) |
| Dec 2017 | $143.95M(-16.3%) | $143.95M(-3.6%) |
| Sep 2017 | - | $149.28M(-5.5%) |
| Jun 2017 | - | $157.96M(-5.7%) |
| Mar 2017 | - | $167.51M(-2.7%) |
| Dec 2016 | $172.07M(+680.0%) | $172.07M(-10.7%) |
| Sep 2016 | - | $192.59M(-4.3%) |
| Jun 2016 | - | $201.26M(+976.9%) |
| Mar 2016 | - | $18.69M(-15.3%) |
| Dec 2015 | $22.06M(+242.1%) | $22.06M(-6.8%) |
| Sep 2015 | - | $23.67M(-5.4%) |
| Jun 2015 | - | $25.02M(+124.6%) |
| Mar 2015 | - | $11.14M(+72.7%) |
| Dec 2014 | $6.45M(-80.3%) | $6.45M(-75.9%) |
| Sep 2014 | - | $26.77M(-0.3%) |
| Jun 2014 | - | $26.84M(+1.3%) |
| Mar 2014 | - | $26.49M(-19.2%) |
| Dec 2013 | $32.79M(-43.5%) | $32.79M(-16.1%) |
| Sep 2013 | - | $39.10M(-13.9%) |
| Jun 2013 | - | $45.40M(-12.2%) |
| Mar 2013 | - | $51.70M(-10.9%) |
| Dec 2012 | $58.00M(-30.3%) | $58.00M |
| Dec 2011 | $83.17M | - |
FAQ
- What is Agios Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual long term liabilities year-on-year change?
- What is Agios Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Agios Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of AGIO is $41.09M
What is the all time high annual long term liabilities for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual total long term liabilities is $359.06M
What is Agios Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, AGIO annual total long term liabilities has changed by -$17.06M (-29.34%)
What is Agios Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AGIO is $36.62M
What is the all time high quarterly long term liabilities for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly total long term liabilities is $359.06M
What is Agios Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AGIO quarterly total long term liabilities has changed by -$17.47M (-32.30%)